Stocks
Organon Financial Statements (OGN) |
||||||||||
| Organonsmart-lab.ru | % | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 03.11.2023 | 26.02.2024 | 03.05.2024 | 07.08.2024 | 01.11.2024 | 01.11.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 1 519 | 1 598 | 1 622 | 1 607 | 1 582 | 6 409 | |||
| Operating Income, bln rub | 0.232 | 312.0 | 414.0 | 386.0 | 390.0 | 1 502 | ||||
| EBITDA, bln rub | ? | 293.0 | 374.0 | 479.0 | 432.0 | 402.0 | 1 687 | |||
| Net profit, bln rub | ? | 58.0 | 546.0 | 201.0 | 195.0 | 359.0 | 1 301 | |||
| OCF, bln rub | ? | 261.0 | 397.0 | 76.0 | 332.0 | -407.5 | 397.5 | |||
| CAPEX, bln rub | ? | 55.0 | 81.0 | 46.0 | 47.0 | 92.9 | 266.9 | |||
| FCF, bln rub | ? | 206.0 | 316.0 | 30.0 | 285.0 | -314.6 | 316.4 | |||
| Dividend payout, bln rub | 74.0 | 73.0 | 70.0 | 79.0 | 74.0 | 296.0 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 127.6% | 13.4% | 34.8% | 40.5% | 20.6% | 22.8% | ||||
| OPEX, bln rub | 675.0 | 603.0 | 543.0 | 553.0 | 533.0 | 2 232 | ||||
| Cost of production, bln rub | 612.0 | 683.0 | 665.0 | 668.0 | 659.0 | 2 675 | ||||
| R&D, bln rub | 137.0 | 134.0 | 112.0 | 116.0 | 111.0 | 473.0 | ||||
| Interest expenses, bln rub | 134.0 | 129.0 | 131.0 | 131.0 | 126.0 | 517.0 | ||||
| Assets, bln rub | 11 012 | 12 058 | 11 891 | 12 154 | 12.8 | 12.8 | ||||
| Net Assets, bln rub | ? | -589.0 | -70.0 | 48.0 | 144.0 | 493.0 | 493.0 | |||
| Debt, bln rub | 8 654 | 8 760 | 8 714 | 8 656 | 8 749 | 8 749 | ||||
| Cash, bln rub | 414.0 | 693.0 | 575.0 | 704.0 | 0.763 | 0.763 | ||||
| Net debt, bln rub | 8 240 | 8 067 | 8 139 | 7 952 | 8 748 | 8 748 | ||||
| Ordinary share price, rub | 17.4 | 14.4 | 18.8 | 20.7 | 19.1 | 30.5 | ||||
| Number of ordinary shares, mln | 255.6 | 255.6 | 255.7 | 257.3 | 257.5 | 257.5 | ||||
| Market cap, bln rub | 4 437 | 3 686 | 4 807 | 5 326 | 4 926 | 7 854 | ||||
| EV, bln rub | ? | 12 677 | 11 753 | 12 946 | 13 278 | 13 674 | 16 602 | |||
| Book value, bln rub | -5 753 | -5 206 | -5 273 | -5 143 | 488 | 488 | ||||
| EPS, rub | ? | 0.23 | 2.14 | 0.79 | 0.76 | 1.39 | 5.05 | |||
| FCF/share, rub | 0.81 | 1.24 | 0.12 | 1.11 | -1.22 | 1.23 | ||||
| BV/share, rub | -22.5 | -20.4 | -20.6 | -20.0 | 1.89 | 1.89 | ||||
| EBITDA margin, % | ? | 19.3% | 23.4% | 29.5% | 26.9% | 25.4% | 26.3% | |||
| Net margin, % | ? | 3.82% | 34.2% | 12.4% | 12.1% | 22.7% | 20.3% | |||
| FCF yield, % | ? | 9.56% | 14.6% | 10.6% | 15.7% | 6.42% | 4.03% | |||
| ROE, % | ? | -99.3% | -1 461% | 2 181% | 694.4% | 263.9% | 263.9% | |||
| ROA, % | ? | 5.31% | 8.48% | 8.80% | 8.23% | 10 202% | 10 202% | |||
| P/E | ? | 7.58 | 3.60 | 4.59 | 5.33 | 3.79 | 6.04 | |||
| P/FCF | 10.5 | 6.85 | 9.46 | 6.36 | 15.6 | 24.8 | ||||
| P/S | ? | 0.72 | 0.59 | 0.76 | 0.84 | 0.77 | 1.23 | |||
| P/BV | ? | -0.77 | -0.71 | -0.91 | -1.04 | 10.1 | 16.1 | |||
| EV/EBITDA | ? | 9.40 | 8.14 | 8.44 | 8.41 | 8.11 | 9.84 | |||
| Debt/EBITDA | 6.11 | 5.59 | 5.31 | 5.04 | 5.19 | 5.19 | ||||
| R&D/CAPEX, % | 249.1% | 165.4% | 243.5% | 246.8% | 119.5% | 177.2% | ||||
| CAPEX/Revenue, % | 3.62% | 5.07% | 2.84% | 2.92% | 5.87% | 4.16% | ||||
| Organon shareholders | ||||||||||
